An ounce of prevention is worth of pound of cure, particularly when it comes to the health of your heart. “The future of cardiovascular disease management is evidence-based prevention — coronary artery plaques can be detected earlier, disease progression can be halted, plaque stabilization, in some cases even regression, can be induced,” says Dr. Rolando deGoma, a board certified cardiologist and clinical lipidologist, and the medical director of Princeton Preventive Cardiology. He began providing evidence-based personalized, preventive treatment in 2001 when it became clear that many high-risk patients were not being treated to the recommended goals. A decade later that future is here. The treatment approach of high-risk patients has finally shifted to evidence-based optimal medical therapy with aggressive cholesterol therapy serving as its foundation. Your health insurance coverage now includes wellness and science-based prevention.
If you are an employee, you and your employer are already paying for this prevention coverage. Participation in a wellness program at the workplace or gym is the first step. But to improve patient outcomes and reduce healthcare cost, you need to take the next step — determining if you are at high risk and then seeking medical treatment to prevent heart attack and stroke at a specialized center. Take a simple test at www.MillionHeartsTest.com.
At Princeton Preventive Cardiology the approach to heart attack and stroke prevention is based on the large cumulative data from many clinical trials that have demonstrated cardiovascular event reduction of about 30 to 40 percent during the duration of the study. Our personalized approach is comprehensive, addressing both patient-modifiable and physician-modifiable risk factors that goes beyond LDL cholesterol. Our event reduction exceeds those reported in clinical trials and the decline continues even 10 years later.
Optimal preventive treatment alters the normal progression of cholesterol plaque build-up in the arteries — preventing plaque rupture (the immediate cause of most heart attacks and strokes), slowing progression, preventing new plaque formation, and even inducing regression. These beneficial effects lower risk resulting in much fewer heart attacks, strokes, deaths, disabilities, stents, heart bypasses, and hospitalizations.
The recent economic conditions have created a sense of urgency to implement major advances in medical science to reduce cost while improving patient outcomes. We support and promote the Million Hearts Initiative by CDC and CMS in its efforts to prevent one million heart attacks and strokes in five years, starting January 1, 2012. A significant component of escalating healthcare costs is the high expenditures from heart disease and stroke — the number one and number three causes of death and disability in the U.S. Advances in medical science in the last 20 years have resulted in a greater understanding of the underlying disease process (atherosclerosis) — how to detect it earlier before it reaches the advanced symptomatic stage and how to prevent its progression. Those at high risk have the most to benefit. The longer the treatment duration, the greater the heart attack and stroke reduction.
Dr. Rolando deGoma, Princeton Preventive Cardiology, 416 Bellevue Avenue Suite 303, Trenton. Two Capital Way Suite 333 Pennington. 1445 Whitehorse-Mercerville Road, Hamilton. 609-396-6363. www.PrincetonPreventiveCardiology.com. See display ad page 16.